(16015810), N. J., (16015813), K. R. C., (14958336), H. H. M., (14942629), S. R., (16015816), C. T., (15038249), C. A. W., . . . (14942641), R. O. H. (2025). Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Lua i Stíl Chicago (17ú heag.)(16015810), Noor Jailkhani, et al. Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.
Lua MLA (9ú heag.)(16015810), Noor Jailkhani, et al. Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.